{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:37Z","timestamp":1792025197724,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014788","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000}}],"reference-count":199,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014788.pub2","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T06:36:10Z","timestamp":1687329370000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Gonadotropin-releasing hormone analogues for endometriosis"],"prefix":"10.1002","volume":"2023","author":[{"given":"Veerle B","family":"Veth","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology; Maastricht University Medical Center (MUMC+); Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majorie MA","family":"van de Kar","sequence":"additional","affiliation":[{"name":"Emergency Department; Laurentius Ziekenhuis; Roermond Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James MN","family":"Duffy","sequence":"additional","affiliation":[{"name":"King's Fertility; The Fetal Medicine Research Institute; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velja","family":"Mijatovic","sequence":"additional","affiliation":[{"name":"Academic Endometriosis Center, Department of Reproductive Medicine; Amsterdam UMC; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques WM","family":"Maas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology; Maastricht University Medical Center (MUMC+); Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"10.1002\/14651858.CD014788.pub2-BIB0001|cit1","first-page":"306","article-title":"Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis","volume":"4","author":"Abdou","journal-title":"Journal of Obstetrics and Gynecology of India"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0002|cit2","first-page":"215","article-title":"Pain of endometriosis: effects of nafarelin and danazol therapy","volume":"39","author":"Adamson","year":"1994","journal-title":"International Journal of Fertility & Menopausal Studies"},{"issue":"7","key":"10.1002\/14651858.CD014788.pub2-BIB0003|cit3","first-page":"413","article-title":"Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group","volume":"42","author":"Agarwal","year":"1997","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1479-828X.1996.tb02924.x","article-title":"Goserelin depot versus danazol in the treatment of endometriosis the Australian\/New Zealand experience","volume":"36","year":"1996","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0005|cit5","first-page":"49","article-title":"Efficacy and safety of slow-release leuprorelin 3,75 mg compared to danazol treatment.\u00a0","volume":"5","author":"Audebert","year":"1997","journal-title":"References en Gynecologie Obstetrique"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/09513599709152533","article-title":"A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone","volume":"11","author":"Bergqvist","year":"1997","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(98)00019-3","article-title":"Effects of triptorelin versus placebo on the symptoms of endometriosis","volume":"69","author":"Bergqvist","year":"1998","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/09513590009167714","article-title":"A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis","volume":"14","author":"Bergqvist A and SCANDET group","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/0002-9378(89)90870-3","article-title":"Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.","volume":"160","author":"Burry","year":"1989","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9378(92)91705-F","article-title":"Nafarelin in the management of endometriosis: quality of life assessment","volume":"166","author":"Burry","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"pp.s13","key":"10.1002\/14651858.CD014788.pub2-BIB0011|cit11","first-page":"0","article-title":"Quality of life during and after treatment of endometriosis with Nafarelin or Danazol (abstract)","volume":"54","author":"Burry","year":"1990","journal-title":"Fertility & Sterility"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0012|cit12","first-page":"431","article-title":"A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis","volume":"57","author":"Chang","year":"1996","journal-title":"Chung Hua i Hsueh Tsa Chih - Chinese Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD014788.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1726-4901(09)70166-2","article-title":"A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan","volume":"68","author":"Cheng","year":"2005","journal-title":"Journal of the Chinese Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0028-2243(94)02016-8","article-title":"A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis","volume":"59","author":"Cirkel","year":"1995","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"Supp 2","key":"10.1002\/14651858.CD014788.pub2-BIB0015|cit15","first-page":"43","article-title":"GnRH analogue depot (triptorelin) versus danazol in the treatment of endometriosis","volume":"7","author":"Cirkel","year":"1993","journal-title":"Gynecological Endocrinology (3rd International Symposium)"},{"issue":"Supp 2","key":"10.1002\/14651858.CD014788.pub2-BIB0016|cit16","first-page":"43","article-title":"Correlation between extent of ovarian suppression and regression of endometriosis: decapeptyl vs danazol","volume":"7","author":"Ochs","year":"1993","journal-title":"Gynecological Endocrinology (3rd International Symposium)"},{"issue":"12","key":"10.1002\/14651858.CD014788.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/oxfordjournals.humrep.a019199","article-title":"Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study","volume":"11","author":"Crosignani","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/s0015-0282(16)57593-1","article-title":"Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin","volume":"63","author":"Dawood","year":"1995","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s0015-0282(16)53755-8","article-title":"Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group","volume":"54","author":"Dlugi","year":"1990","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s0015-0282(16)60543-5","article-title":"Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study","volume":"51","author":"Dmowski","year":"1989","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1471-0528.1994.tb13681.x","article-title":"Can hormone replacement therapy be used during medical therapy of endometriosis?","volume":"101","author":"Edmonds","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0002-9378(89)90739-4","article-title":"Buserelin versus danazol in the treatment of endometriosis-associated infertility","volume":"161","author":"Fedele","year":"1989","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0015-0282(16)55975-5","article-title":"Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.contraception.2009.08.003","article-title":"Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue","volume":"81","author":"Ferreira","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","article-title":"Prevention of estrogen deficiency\u2013related bone loss with human parathyroid hormone\u2013(1-34)","volume":"280","author":"Finkelstein","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/jcem.84.4.5643","article-title":"Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis","volume":"84","author":"Finkelstein","year":"1999","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/s0015-0282(00)00690-7","article-title":"Gonadotropin-releasing hormone agonist plus \u201cadd-back\u201d hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial","volume":"74","author":"Franke","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1479-828x.1991.tb01807.x","article-title":"A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol","volume":"31","author":"Fraser","year":"1991","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000052848","article-title":"Steroidal \u2018Add-Back\u2019 Therapy in Patients Treated with GnRH Agonists","volume":"45","author":"Freundl","year":"1998","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1447-0756.1993.tb00389.x","article-title":"Hormone treatment related bone mineral content changes in Japanese women with endometriosis","volume":"19","author":"Fukushima","year":"1993","journal-title":"Asia-Oceania Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/0020-7292(95)02510-j","article-title":"Changes in bone mineral content following hormone treatment for endometriosis.\u00a0","volume":"50","year":"1995","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000010059","article-title":"Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists","volume":"47","author":"Gnoth","year":"1999","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.fertnstert.2006.11.044","article-title":"The levonorgestrel-releasing intrauterine system and endometriosis staging","volume":"87","author":"Gomes","year":"2007","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2014a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertility & Sterility"},{"issue":"8","key":"10.1002\/14651858.CD014788.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial","volume":"318","author":"Henzl","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0037|cit37","unstructured":"Henzl MR Role of nafarelin in the management of endometriosis Journal of Reproductive Medicine 1989 34 12 Suppl 1021 4"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0038|cit38","first-page":"30","article-title":"Treatment of endometriosis with the GnRH agonist naferelin acetate","volume":"36","author":"Jacobs","year":"1991","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000414897","article-title":"Evaluation of a GnRH agonist (nafarelin) versus danazol for treatment of endometriosis","volume":"16","author":"Moghissi","year":"1987","journal-title":"Contributions to Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0040|cit40","first-page":"S84","article-title":"A prospective randomised double-blind trial of 3 versus 6 months nafarelin therapy for symptoms of endometriosis","volume":"58","author":"Hornstein","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0015-0282(16)57530-X","article-title":"Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain","volume":"63","author":"Hornstein","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: A 12- month study","volume":"1","author":"Hornstein","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0015-0282(16)57779-6.","article-title":"Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial","volume":"64","author":"Howell","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0044|cit44","first-page":"97","article-title":"Delayed oral estradiol combined with leuprolide increases endometriosis-related pain","volume":"4","author":"Hurst","year":"2000","journal-title":"Journal of the Society of Laparoendoscopic Surgeons"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000052978","article-title":"Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis","volume":"52","author":"Irahara","year":"2001","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0046|cit46","unstructured":"Jelley RY Magill PJ The effect of LHRH agonist therapy in the treatment of endometriosis (English experience) Progress in Clinical & Biological Research 1986 225 227 38"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0047|cit47","unstructured":"Jelley RY Multicentre open comparative study of buserelin and danazol in the treatment of endometriosis British Journal of Clinical Practice 1986 48 Suppl 64 8"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/s0015-0282(16)53574-2","article-title":"A comparison of nafarelin acetate and danazol in the treatment of endometriosis","volume":"53","author":"Kennedy","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0015-0282(16)57900-x","article-title":"Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis","volume":"64","author":"Kiilholma","year":"1995","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9378(88)90128-7","article-title":"Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis","volume":"158","author":"Lemay","year":"1988","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000414894","article-title":"LH-RH agonist treatment of endometriosis","volume":"16","author":"Lemay","year":"1987","journal-title":"Contributions to Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0029-7844(98)00341-x","article-title":"Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic pain study group","volume":"93","author":"Ling","year":"1999","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0015-0282(16)58023-6","article-title":"Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis","volume":"65","author":"Makarainen","year":"1996","journal-title":"Fertility & Sterility"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1067\/mob.2000.106846","article-title":"Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial","volume":"182","author":"Miller","year":"2000","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0055|cit55","first-page":"211","article-title":"Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan","volume":"225","author":"Minaguchi","year":"1986","journal-title":"Progress in Clinical & Biological Research"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/s0015-0282(98)00086-7","article-title":"Goserelin acetate (Zoladex) with or without hormone replacement. Therapy for the treatment of endometriosis","volume":"69","author":"Moghissi","journal-title":"Fertility & Sterility"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(16)53574-2","article-title":"A comparison of nafarelin acetate and danazol in the treatment of endometriosis","volume":"53","author":"Kennedy","year":"1990","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)54893-6","article-title":"Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up The Nafarelin European Endometriosis Trial Group (NEET)\u00a0","volume":"57","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/oxfordjournals.humrep.a136067","article-title":"Serum-soluble CD23 in patients with endometriosis and the effect of treatment with danazol and leuprolide acetate depot injection","volume":"10","author":"Odukoya","year":"1995","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/0002-9378(94)90136-8","article-title":"Nafarelin therapy in endometriosis: long-term effects on bone mineral density","volume":"171","author":"Orwoll","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00404-020-05691-3","article-title":"Comparison of effect of preoperative dienogest and gonadotropin\u2011releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas","volume":"302","author":"Ozaki","journal-title":"Archives of Gynecology and Obstetrics\u00a0"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0062|cit62","first-page":"173","article-title":"Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol","volume":"46","author":"Palagiano","year":"1994","journal-title":"Minerva Ginecologica"},{"issue":"7","key":"10.1002\/14651858.CD014788.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Human Reproduction"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014788.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.fertnstert.2007.07.720","article-title":"Comparative study of the influence of the levonorgestrel intra-uterine system and the GnRH analogues on cardiovascular risk markers in patients with endometriosis","volume":"88","author":"Vieira","year":"2007","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.fertnstert.2006.02.082","article-title":"The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis","volume":"86","author":"Sa Rosa e Silva","year":"2006","journal-title":"Fertility & Sterility"},{"issue":"10","key":"10.1002\/14651858.CD014788.pub2-BIB0066|cit66","first-page":"1013","article-title":"Zoladex versus danazol in endometriosis therapy","volume":"93","author":"Allen","year":"1993","journal-title":"Journal of the American Osteopathic Association"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0067|cit67","first-page":"198","article-title":"Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol","volume":"82","author":"Rock","year":"1993","journal-title":"Obstetrics & Gynecology"},{"issue":"pp.s49","key":"10.1002\/14651858.CD014788.pub2-BIB0068|cit68","article-title":"A multicenter comparison of GnRH agonist (Zoladex) and danazol in the treatment of endometriosis\u00a0","volume":"56","author":"Rock","year":"1991","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/0002-9378(90)90437-c","article-title":"Nafarelin versus danazol in the treatment of endometriosis","volume":"162","author":"Rolland","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0070|cit70","first-page":"523","article-title":"Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis","volume":"23","author":"Rotondi","year":"2002","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis International"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315.","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0073|cit73","first-page":"329","article-title":"Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis - comparison of two dose regimens","volume":"4","author":"Shaw","year":"1986","journal-title":"Clinical Reproduction and Fertility"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/0002-9378(90)90433-8","article-title":"Nafarelin in the treatment of pelvic pain caused by endometriosis","volume":"162","author":"Shaw","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-0029-1212129","article-title":"Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin","volume":"107","author":"Sillem","year":"1999","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0076|cit76","first-page":"301","article-title":"Influence of GnRH analogue on the intensification of endometriosis symptoms and infertility treatment","volume":"57 Suppl 1","author":"Skrzypulec","year":"2004","journal-title":"Wiadomosci Lekarskie"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijgo.2012.01.009","article-title":"Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis","volume":"117","author":"Strowitzki","year":"2012","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/humrep\/dep46","article-title":"Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial","volume":"25","author":"Strowitzki","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/jcem.75.2.1386374","article-title":"Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: A prospective randomized trial","volume":"75","author":"Surrey","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD014788.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0029-7844(02)01945-2","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/s0015-0282(99)00636-6","article-title":"Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\"draw-back\" therapy)","volume":"73","author":"Tahara","year":"2000","journal-title":"Fertility & Sterility"},{"issue":"10","key":"10.1002\/14651858.CD014788.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/jog.13420","article-title":"Curative effect of 1.88-mg and 3.75-mg gonadotrophin-releasing hormone agonist on stage III\u2013IV endometriosis: Randomized controlled study","volume":"43","author":"Tang","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0015-0282(16)59885-9","article-title":"Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol","volume":"49","author":"Tummon","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0015-0282(16)60542-3","article-title":"A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis","volume":"51","author":"Tummon","year":"1989","journal-title":"Fertility & Sterility"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0015-0282(16)57175-1","article-title":"Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study","volume":"62","author":"Vercellini","year":"1994","journal-title":"Fertility & Sterility"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/s0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: A multicenter, randomized, double-blind study","volume":"66","author":"Vercellini","journal-title":"Fertility & Sterility"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/0002-9378(93)90126-4.","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0015-0282(16)58682-8","article-title":"The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis","volume":"33","author":"Whitehouse","year":"1990","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.3390\/jcm10051085","article-title":"Role of medical therapy in the treatment of endometriosis associated pelvic pain: a randomized controlled study","volume":"12","author":"Zupi","year":"2005","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0091|cit91","first-page":"241","article-title":"CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists","volume":"32","author":"Acien","year":"1989","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0092|cit92","unstructured":"Adiyono W Adisusianto I The impact of combination laparoscopic surgery and GNRH analog on quality of life endometriosis patients XVIII FIGO World Congress of Gynecology and Obstetrics 5-10 November Kuala Lumpur, Malaysia 2006 143"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/934164","article-title":"Treatment of endometriosis with the GnRHa deslorelin and add-back estradiol and supplementary testosterone","volume":"2015","author":"Agarwal","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1471-0528.2009.02319.x","article-title":"Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain","volume":"116","author":"Al-Azemi","year":"2009","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0002-9378(90)90438-d","article-title":"Effects of nafarelin versus danazol on lipids and calcium metabolism","volume":"162","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0096|cit96","first-page":"7","article-title":"Treatment of pelvic endometriosis with goserelin acetate or nafarelin acetate. Comparative study","volume":"68","author":"Calvo Lugo","year":"2000","journal-title":"Ginecologia y Obstetricia de Mexico"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0097|cit97","first-page":"82","article-title":"Comparative study of gestrinone, danazol and decapeptyl CR in the treatment of endometriosis","author":"Chan","year":"1993","journal-title":"2nd International Scientific Meeting of the Royal College of Obstetricians"},{"issue":"9","key":"10.1002\/14651858.CD014788.pub2-BIB0098|cit98","first-page":"797","article-title":"Randomized blind, parallel-controlled and multiple centre clinical trial on the effectiveness and safety of leuprolide acetate in the treatment of endometriosis","volume":"18","author":"Qiao","year":"2009","journal-title":"Chinese Journal of New Drugs - Zhongguo"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0099|cit99","first-page":"656","article-title":"Buserelin acetate implants in the treatment of pain in endometriosis","volume":"84","author":"Choktanasiri","year":"2001","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD014788.pub2-BIB0100|cit100","first-page":"1025","article-title":"Clinical experience treating endometriosis with nafarelin","volume":"34","author":"Claesson","year":"1989","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/aogs.1989.68.s150.27","article-title":"The medical treatment of mild endometriosis","volume":"150","author":"Cooke","year":"1989","journal-title":"Acta Obstetricia et Gynecologica Scandinavica - Supplement"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0102|cit102","first-page":"253","article-title":"A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis","author":"Dawood","year":"1990","journal-title":"Current Concepts in Endometriosis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD014788.pub2-BIB0103|cit103","first-page":"21","article-title":"Comparitive study of buserelin versus danazol in the management of endometriosis","volume":"3","author":"Dmowski","year":"1989","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0104|cit104","first-page":"410","article-title":"Bone mass in endometriosis patients treated with GnRH agonist implant or danazol","volume":"77","author":"Dodin","year":"1991","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0015-0282(16)60783-5","article-title":"Administration of nasal buserelin as compared with subcutaneous buserelin implant for endometriosis","volume":"52","author":"Donnez","year":"1989","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.fertnstert.2003.07.013","article-title":"Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis","volume":"81","author":"Donnez","year":"2004","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2265.1992.tb02338.x","article-title":"A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone","volume":"37","author":"Eldred","year":"1992","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0015-0282(16)60363-1","article-title":"Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis","volume":"50","author":"el-Roeiy","year":"1988","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Lucas","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-9-88","article-title":"Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial","volume":"9","author":"Ferrero","year":"2011","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0015-0282(16)55011-0","article-title":"On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol","volume":"57","author":"Franssen","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0029-7844(95)00475-0","article-title":"Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia","volume":"87","author":"Fraser","year":"1996","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1054\/ebog.2000.0139","article-title":"Empirical leuprolide treatment of women with suspected endometriosis was effective in reducing chronic pain","volume":"2","author":"Harada","year":"2000","journal-title":"Evidence-based Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0115|cit115","first-page":"343","article-title":"Nafarelin: a new medical therapy for endometriosis","volume":"323","author":"Henzl","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Imani R Thai-Cuarto D Jimenez R Burke J Kroll R O'Brien C Petal study: Safety, tolerability and effectiveness of elagolix, an oral GnRH antagonist for endometriosis Fertility & Sterility 2009 S111 S112 10.1016\/j.fertnstert.2009.07.1100","DOI":"10.1016\/j.fertnstert.2009.07.1100"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/s0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertility & Sterility"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD014788.pub2-BIB0118|cit118","first-page":"s5","article-title":"Leuprolide acetate in the management of endometriosis-associated pain: A multicenter, evaluator-blind, comparative clinical trial","volume":"11","author":"Luciano","year":"2004","journal-title":"Global Congress of Gynecologic Endoscopy 33rd Annual Meeting of the AAGL \"Advancing Minimally Invasive Gynecology Worldwide\""},{"issue":"10","key":"10.1002\/14651858.CD014788.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF03348925","article-title":"Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis","volume":"16","author":"Magini","year":"1993","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0015-0282(16)58023-6","article-title":"Pseudomenopause treatment for endometriosis: The endocrine effects of danazol compared with the use of the LH-RH agonist goserelin","volume":"11","author":"Maouris","year":"1991","journal-title":"Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0121|cit121","first-page":"61","article-title":"Comparison of the endocrine effects of danazol and the LHRH agonist goserelin (Zoladex) in the treament of endometriosis","author":"Maouris","year":"1989","journal-title":"Silver Jubilee British Congress of Obstetrics and Gynaecology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD014788.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/s0029-7844(99)00635-3","article-title":"A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis","volume":"95","author":"Matalliotakis","year":"2000","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0123|cit123","first-page":"75","article-title":"Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis","volume":"49","author":"Matalliotakis","year":"2004","journal-title":"International Journal of Fertility & Womens Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0124|cit124","first-page":"69","article-title":"A comparative study between buserelin and danazol in the treatment of endometriosis","volume":"40","author":"Matta","year":"1988","journal-title":"The British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0125|cit125","first-page":"337","article-title":"Leuprolide acetate for the treatment of endometriosis","volume":"323","author":"Miller","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0002-9378(96)70258-2","article-title":"A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment","volume":"175","author":"Mukherjee","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology\u00a0"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0015-0282(16)58351-4","article-title":"Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study","volume":"65","author":"Newton","year":"1996","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/s0015-0282(00)01537-5","article-title":"Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up","volume":"74","author":"Pierce","journal-title":"Fertility & Sterility"},{"issue":"10","key":"10.1002\/14651858.CD014788.pub2-BIB0129|cit129","first-page":"761","article-title":"Alendronate for the prevention of bone mineral loss during gonadotropin-releasing hormone agonist therapy","volume":"48","author":"Ripps","journal-title":"The Journal of Reproductive Medicine"},{"issue":"70 Suppl 2","key":"10.1002\/14651858.CD014788.pub2-BIB0130|cit130","first-page":"45","article-title":"A randomised comparative study of the effects of goserelin and danazol for the treatment of endometriosis","volume":"4","author":"Shaw","year":"1990","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0015-0282(16)55205-4","article-title":"An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team","volume":"58","author":"Shaw","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"Suppl","key":"10.1002\/14651858.CD014788.pub2-BIB0132|cit132","first-page":"69","article-title":"Goserelin depot: an analog of LHRH for the treatment of endometriosis","volume":"16","author":"Shaw","year":"1990","journal-title":"Drugs Under Experimental & Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2508.2001.00407.x","article-title":"A prospective randomized open study comparing goserelin (Zoladex) plus surgery and surgery alone in the management of ovarian endometriomas","volume":"10","author":"Shaw","year":"2001","journal-title":"Gynaecological Endoscopy"},{"issue":"8","key":"10.1002\/14651858.CD014788.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1210\/jcem.84.8.5920","article-title":"Use of vitamin K2 (Menatetrenone) and 1,25- dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0412.1997.tb07989.x","article-title":"Pre- and postoperative therapy with GnRH agonist for endometrial resection. A prospective, randomized study","volume":"76","author":"Sorensen","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2508.1997.490483.x","article-title":"A prospective randomized trial of the effect of preoperative endometrial inhibition on the long-term outcome of transcervical endometrial resection","volume":"6","author":"Sowter","year":"1997","journal-title":"Gynaecological Endoscopy"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/deh035","article-title":"The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial","volume":"19","author":"Soysal","year":"2004","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0138|cit138","first-page":"581","article-title":"Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report","volume":"81","author":"Surrey","year":"1993","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0015-0282(16)57476-7","article-title":"Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone \"add-back\" therapy","volume":"63","author":"Surrey","year":"1995","journal-title":"Fertility & Sterility"},{"issue":"9","key":"10.1002\/14651858.CD014788.pub2-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jog.13023","article-title":"Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis","volume":"42","author":"Takaesu","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"issue":"12","key":"10.1002\/14651858.CD014788.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/oxfordjournals.humrep.a137980","article-title":"Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study","volume":"8","author":"Tapanainen","year":"1993","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(97)81853-5","article-title":"Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis","volume":"67","author":"Taskin","year":"1997","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0143|cit143","unstructured":"Toomey C Krauss B Hammerschlag R Burry K Endometriosis: traditional medicine vs hormone therapy National Centre for Complementary and Alternative Medicine 2003"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1210\/jcem-69-6-1097","article-title":"Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis","volume":"69","author":"Valimaki","year":"1989","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200969060-00002","article-title":"Endometriosis: current therapies and new pharmacological developments","volume":"69","author":"Vercellini","year":"2009","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1520-6394(1998)7:4<171::AID-DA5>3.0.CO;2-D","article-title":"Depressive symptoms associated with gonadotropin-releasing hormone agonists","volume":"7","author":"Warnock","year":"1998","journal-title":"Depression and Anxiety"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0015-0282(16)57417-2","article-title":"Short-term lupron or danazol therapy for pelvic endometriosis","volume":"63","author":"Wright","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0148|cit148","first-page":"175","article-title":"A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the university of Southern California experience","volume":"225","author":"Yee","year":"1986","journal-title":"Progress in Clinical & Biological Research"},{"issue":"6","key":"10.1002\/14651858.CD014788.pub2-BIB0149|cit149","first-page":"1470","article-title":"Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study","volume":"10","author":"Ylikorkala","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0150|cit150","doi-asserted-by":"crossref","unstructured":"Aisaka K Nakagawa K Uesato T Miwa A Koshino T Ooka F Effectiveness of long term GN-RH agonist administration for treatment of endometriosis combined with estrogen-progestogen add back therapy XVI FIGO World Congress of O & G 2000 2000 doi.org\/10.1016\/S0020-7292(00)82576-X","DOI":"10.1016\/S0020-7292(00)82576-X"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0151|cit151","doi-asserted-by":"crossref","unstructured":"Archer DF Luciano A Carson S New low dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for endometriosis-associated pain Fertility & Sterility https:\/\/doi.org\/10.1016\/j.fertnstert.2004.07.182","DOI":"10.1016\/j.fertnstert.2004.07.182"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0152|cit152","article-title":"Gonadotropin-releasing hormone analoque (leuprolide) plus hormone replacement therapy for the treatment of endometriosis: a randomised controlled trial","volume":"67","author":"Gregoriou","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0153|cit153","doi-asserted-by":"crossref","unstructured":"Long Q A randomized clinical trial of GnRHa and add-back therapy in the treatment of endometriosis International Journal of Gynecology and Obstetrics\u00a0 2009 S247 10.1016\/S0020-7292","DOI":"10.1016\/S0020-7292(09)60913-9"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0154|cit154","unstructured":"Vella A Brincat M Galea R Muscat Baron Y Skin thickness and bone density: effect of add-back therapy in women on GnRh analogue 27th British Congress of Obstetrics and Gynaecology 1995"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0301-2115(98)00028-1","article-title":"Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study","volume":"79","author":"Audebert","year":"1998","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"issue":"10","key":"10.1002\/14651858.CD014788.pub2-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011031","article-title":"Laparoscopic surgery for endometriosis","author":"Bafort","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0157|cit157","first-page":"1161","article-title":"M\u00fcllerianosis","volume":"10","author":"Batt","journal-title":"Histology & Histopathology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: management of women with endometriosis.","volume":"2","author":"Becker","year":"2022","journal-title":"Human Reproduction Open"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1749-6632.1997.tb52155.x","article-title":"Etiopathology of endometriosis","volume":"816","author":"Bontis","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0160|cit160","doi-asserted-by":"crossref","unstructured":"Progestagens and anti-progestagens for pain associated with endometriosis Cochrane Database of Systematic Reviews 2012 3 10.1002\/14651858.CD002122.pub2","DOI":"10.1002\/14651858.CD002122.pub2"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0161|cit161","doi-asserted-by":"crossref","unstructured":"Oral contraceptives for pain associated with endometriosis Cochrane Database of Systematic Reviews 2018 5 10.1002\/14651858.CD001019","DOI":"10.1002\/14651858.CD001019.pub3"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","article-title":"Pathogenesis and pathophysiology of endometriosis","volume":"3","author":"Burney","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD014788.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003678.pub3","article-title":"Pre- and postsurgical medical therapy for endometriosis surgery","author":"Chen","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0164|cit164","first-page":"196","article-title":"Epidemiology and risk factors associated with laparoscopicaly diagnosed typical and atypical endometriosis among Egyptian women","volume":"11","author":"Darwish","year":"2006","journal-title":"Middle East Fertility Society Journal"},{"issue":"8","key":"10.1002\/14651858.CD014788.pub2-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/1471-0528.16157","article-title":"A core outcome set for future endometriosis research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Warner","year":"1997","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0167|cit167","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006568.pub3","article-title":"Chinese herbal medicine for endometriosis","author":"Flower","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0168|cit168","doi-asserted-by":"crossref","unstructured":"Progesterone receptor modulators for endometriosis Cochrane Database of Systematic Reviews 2017 7 10.1002\/14651858.CD009881.pub2","DOI":"10.1002\/14651858.CD009881.pub2"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice: endometriosis","volume":"25","author":"Giudice","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0170|cit170","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0171|cit171","unstructured":"Gonadotrophin antagonists for pain associated with endometriosis Cochrane Database of Systematic Reviews 2014 12 10.1002\/14651858.CD011446"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0172|cit172","first-page":"1420","article-title":"Managing the misplaced: approach to endometriosis","volume":"11","author":"Jackson","year":"2006","journal-title":"Canadian Family Physician\u00a0"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12905-021-01545-5","article-title":"Treatment of endometriosis: a review with comparison of 8 guidelines","volume":"1","author":"Kalaitzopoulos","year":"2021","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.rbmo.2013.09.020","article-title":"What is the societal burden of endometriosis-associated symptoms? a prospective Belgian study","volume":"28","author":"Klein","year":"2013","journal-title":"Reproductive Biomedical Online"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0175|cit175","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 \u00a0Available from training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3109\/00016345509158287","article-title":"The pathogenesis of endometriosis; an experimental study","volume":"34","author":"Levander","year":"1955","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ogc.2012.10.002","article-title":"Endometriosis and Infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility","volume":"39","author":"Macer ML and Taylor","year":"2013","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/oxfordjournals.humrep.a137377","article-title":"Prevalence and genesis of endometriosis","volume":"6","author":"Mahmood","year":"1991","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD014788.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0029-7844(95)00458-0","article-title":"Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates","volume":"87","author":"Mathias","year":"1996","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014788.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","article-title":"High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners.","volume":"92","author":"Meuleman","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/GRF.0000000000000292","article-title":"Medical Management of Endometriosis","volume":"3","author":"Rafique","year":"2017","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0182|cit182","doi-asserted-by":"crossref","unstructured":"Pathogenesis of endometriosis Reproductive Biomedicine Online 21 1 4 5","DOI":"10.1016\/j.rbmo.2010.03.031"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0002-9378(40)91238-8","article-title":"The development of the implantation theory for the origin of peritoneal endometriosis","volume":"40","author":"Sampson","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0184|cit184","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Guyatt GH Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February\u00a02021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook 2021"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0185|cit185","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-011-3864-2_14","volume-title":"GnRH analogues in the treatment of endometriosis -rationale and efficacy","author":"Shaw","year":"1991"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/humrep\/des073","article-title":"The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres","volume":"27","author":"Simoens","year":"2021","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0187|cit187","first-page":"327\u201346","article-title":"Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications","volume":"17(3)","author":"Stratton","year":"2011","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/humrep\/11.suppl_3.53.","article-title":"Theories on the pathogenesis of endometriosis","volume":"3","author":"Linden","year":"1996","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD014788.pub2-BIB0189|cit189","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011169.pub2","article-title":"Selective oestrogen receptor modulators (SERMs) for endometriosis","author":"Van Hoesel","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"5","author":"Vercellini","year":"2014","journal-title":"Nature Reviews, Endocrinology"},{"issue":"33(3)","key":"10.1002\/14651858.CD014788.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humrep\/dex354","article-title":"Time to redefine endometriosis including its pro-fibrotic nature","volume":"1","author":"Vigano","year":"2018","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD014788.pub2-BIB0192|cit192","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bpobgyn.2004.01.007","article-title":"Endometriosis: epidemiology and aetiological factors","volume":"18","author":"Vigan\u00f2","year":"2004","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD014788.pub2-BIB0193|cit193","first-page":"41","article-title":"Epidemiology of endometriosis-associated infertility","volume":"34","author":"Wheeler","year":"1989","journal-title":"Journal of Reproductive Medicine"},{"issue":"33","key":"10.1002\/14651858.CD014788.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1990.tb00501.x","article-title":"The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.","volume":"3","author":"Whitehouse","year":"1990","journal-title":"Clinical Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599009024979","article-title":"Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis","volume":"4","author":"Ylikorkala","year":"1990","journal-title":"Gynaecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD014788.pub2-BIB0196|cit196","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007864.pub2","article-title":"Acupuncture for pain in endometriosis","author":"Zhu","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD014788.pub2-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD014788.pub2-BIB0198|cit198","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008475.pub2","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Brown","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD014788.pub2-BIB0199|cit199","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001297","article-title":"Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density","author":"Farmer","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:36:09Z","timestamp":1760333769000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014788.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":199,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014788.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}